SERPINE1 and metabolic bone disorder: Plasminogen activator inhibitor-1 (PAI-1) (SerpinE1), an inhibitor of plasminogen activators, is involved in the pathophysiology of various bone metabolic disorders through its negative effects on bone tissues as an adipokine [12].